FDA currently reviewing the ability of VESTEX® to reduce COVID-19. While the FDA has not yet reviewed the ability of products protected by VESTEX® to reduce COVID-19, preliminary research has documented results […]
Don’t risk taking body fluids, bacteria or viruses home anymore. VESTEX is the company to go to. They are approved by the FDA and work the way advertise. They are […]
A new report from the World Health Organization (WHO) and the London School of Hygiene & Tropical Medicine (LSHTM) is calling for more urgency on efforts to develop a maternal […]
One thing that will haunt me and many health care personnel in both acute care and LTCFs forever is that so many people died without a family member at their […]
Guest Author: Sherrie Dornberger RN, GDCN, CADDCT, CDP, CDONA, FACDONA Executive Director, National Association of Directors of Nursing Administration in Long Term Care (NADONA) As a professional nurse turned patient, I have personally experienced the …
Guest Author: Richard Gelula, MSW Executive Director, The National Consumer Voice for Quality Long-Term Care Among the most important responsibilities in caring for people in nursing homes and other long-term care settings is taking the time to learn w…
Guest Author: Nicole Brandt, PharmD, MBA, BCPP, CGP, FASCP Professor, Geriatric Pharmacotherapy, Pharmacy Practice and Science UMB School of Pharmacy Director, Clinical and Educational Programs of Peter Lamy Center Drug Therapy and Aging As a consultan…
Author: CDC Division of Foodborne, Waterborne, and Environmental Diseases (DFWED) Wondering how antibiotic resistance in foodborne bacteria has changed over time? You’re in luck. With CDC’s new interactive tool, NARMS Now: Human Data, you can view trends in antibiotic resistance over the past two decades for four bacteria transmitted commonly through food: Campylobacter, E. coli
The latest CDC Vital Signs includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. During the next five years, with investments, CDC’s efforts to combat C. difficile infections and antibiotic resistance under the National Strategy to Combat Antibiotic Resistant Bacteria,
The latest CDC Vital Signs includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. During the next five years, with investments, CDC’s efforts to combat C. difficile infections and antibiotic resistance under the National Strategy to Combat Antibiotic Resistant Bacteria,
The latest CDC Vital Signs includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. During the next five years, with investments, CDC’s efforts to combat C. difficile infections and antibiotic resistance under the National Strategy to Combat Antibiotic Resistant Bacteria,
CDC’s Dr. Scott Fridkin Senior Advisor for Antibiotic Resistance in Health care Today CDC released its latest Vital Signs report, which includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. The report includes recommendations that would impact how health care
Guest Author – Jason G. Newland, MD MEd FPIDS Medical Director of Patient Safety and Systems Reliability Children’s Mercy Hospitals & Clinics, Kansas City, Missouri Antibiotic resistance is one of the nation’s most pressing public health threats. Yesterday CDC led several important discussions at the White House Forum on Antibiotic Stewardship. This forum is a
Author: CDC The White House is convening the Forum on Antibiotic Stewardship on Tuesday, June 2, 2015 to bring together key human and animal health constituencies involved in the development, promotion, and implementation of activities to improve antib…
Antibiotic resistance, the ability of bacteria to resist the effects of drugs, is perhaps the single most important infectious disease threat of our time. Although some people are at greater risk than others, no one can completely avoid the risk of antibiotic-resistant infections. These infections affect real people and they can be horrible for patients. […]